Tag: ZLD

TGA cannabis changes pot stocks Therapeutic Goods Administration cannabidiol CBD over-the-counter OTC

Drawbacks of the TGA’s cannabis changes for listed pot stocks

Having been subject to a harsh reality check over the last year or so, the ASX-listed cannabis sector is applauding the local medicine regulator’s endorsement of the weed as an effective therapy that ...
Zelira Therapeutics ASX ZLD Peripheral Arterial Disease Diabetic Neuropathies

Zelira Therapeutics targets arterial disease and diabetic illnesses with medicinal cannabis

Medical cannabis company Zelira Therapeutics (ASX: ZLD) has committed to a binding five-year agreement with US-based company Cardiovascular Solutions of Central Mississippi (CVSCM) to develop and comm...
Zelira Therapeutics medical cannabis trial treat insomnia ASX ZLD phase 1b 2a

Zelira Therapeutics reveals more positive results from medical cannabis trial to treat insomnia

Zelira Therapeutics (ASX: ZLD) has announced its Phase 1b/2a medicinal cannabis trial to treat insomnia has met both its primary and secondary endpoints. The company today confirmed it has received...
Zelira Therapeutics primary endpoints medicinal cannabis trial insomnia ASX ZLD

Zelira Therapeutics meets primary endpoints for medical cannabis trial to treat insomnia

Biopharmaceutical company Zelira Therapeutics (ASX: ZLD) has announced positive results from a “first of its kind” phase 1b/2a trial using medicinal cannabis to treat chronic insomnia. The results ...
Health House Holdings Zelda Therapeutics ASX ZLD medicinal cannabis distribution Australasia UK

Health House Holdings to distribute Zelda Therapeutics’ medicinal cannabis throughout Australasia and UK

Zelda Therapeutics’ (ASX: ZLD) medicinal cannabis products will be distributed across Australasia and the United Kingdom under a new agreement with Health House Holdings Ltd. The agreement follows ...
Zelda Therapeutics ASX ZLD opioid epidemic crisis medicinal cannabis

Zelda Therapeutics granted approval to trial medicinal cannabis in tackling the opioid epidemic

Bio-pharmaceutical company Zelda Therapeutics (ASX: ZLD) has taken a decisive step towards mitigating the effects of the growing opioid epidemic that is gripping several Western countries including Au...
SUDA Pharmaceuticals Zelda Therapeutics ASX SUD ZLD medicinal cannabis oral spray

SUDA Pharmaceuticals and Zelda Therapeutics to develop novel medicinal cannabis oral spray

Drug delivery specialist company SUDA Pharmaceuticals (ASX: SUD) has unveiled a deal with Zelda Therapeutics (ASX: ZLD) in the form of a fully funded feasibility and option agreement. The agreement...
Zelda Therapeutics ASX ZLD insomnia trial cannabis patient dosing

Zelda Therapeutics commences its ‘pioneering’ insomnia trial using cannabis

Dual-listed biopharma company Zelda Therapeutics (ASX: ZLD) has kicked off its “pioneering” insomnia trial by dosing its first patient which it says represents a starting point for a wave of research ...
Zelda Therapeutics ASX ZLD Institutional Review Board cannabis trial paediatric autism

IRB approval paves way for Zelda to begin cannabis trials in paediatric autism

Zelda Therapeutics (ASX: ZLD) has gained Institutional Review Board approval to trial its cannabinoid-based formulations on children suffering from autism, which was the final regulatory hurdle to jum...
Zelda Therapeutics ASX ZLD Curtin University pancreatic cancer research

Zelda Therapeutics broadens pancreatic cancer research as precursor to human trials

Zelda Therapeutics (ASX: ZLD) and West Australian-based Curtin University have broadened their pancreatic cancer research program to focus on in vivo animals when investigating the effect of Zelda’s m...
Zelda Therapeutics ASX ZLD US stock market listing

Zelda Therapeutics announces US stock market listing

Zelda Therapeutics (ASX: ZLD), an Australian biotech company focusing on medical cannabis, has announced that its shares have now been approved for trading on the OTCQB Venture Market (OTCQB), a tradi...
Zelda Therapeutics ASX ZLD children’s hospital medicinal cannabis autism study

Zelda Therapeutics teams up with US children’s hospital for medicinal cannabis autism study

Zelda Therapeutics (ASX: ZLD) has teamed up with a US children’s hospital to kick-off its observational study on treating paediatric autism with its cannabinoid-based formulations. The study is due...
Zelda Therapeutics ZLD ASX medicinal cannabis trial treat insomnia

Zelda Therapeutics gets go ahead for medicinal cannabis trial to treat insomnia

In an Australian first, Zelda Therapeutics (ASX: ZLD) has been given the go ahead to begin its Australian medicinal cannabis trial for treating chronic insomnia sufferers. “This has been a very rig...
Zelda Therapeutics ZLD treating autism medical cannabis

Treating autism with medicinal cannabis returns positive results for Zelda Therapeutics

The Board of Zelda Therapeutics (ASX: ZLD) has sponsored an observation autism trial in Chile, demonstrating successful results for treating the core symptoms of autism with medicinal cannabis extract...
Zelda Therapeutics ZLD manufacturing distribution agreement

Zelda Therapeutics enters strategic manufacturing and distribution agreement

Zelda Therapeutics (ASX: ZLD) has entered into a strategic manufacturing and distribution agreement with Knop Laboratories SA. Key Highlights: Zelda Therapeutics to work closely with leading C...
Zelda Therapeutics breast cancer study cannabinoids

Zelda Therapeutics reports positive results in breast cancer study using cannabinoids

Zelda Therapeutics (ASX: ZLD) has reported positive results from its ongoing pre-clinical research into the use of cannabinoids as anti-cancer agents. Key Highlights: Follows on from initial r...